Lung Cancer Screening in Portugal: A PULMONALE Pilot Project

Authors

  • Fernanda Estevinho Serviço de Oncologia Médica. Unidade Local de Saúde de Matosinhos. Matosinhos. Portugal. https://orcid.org/0000-0002-2694-3993
  • Bárbara Parente Serviço de Oncologia. Hospital CUF Porto. Porto. Portugal.; Unidade do Cancro do Pulmão. Instituto CUF Oncologia. Hospital CUF Porto. Porto. Portugal.
  • Fernando Barata Departamento de Oncologia. Unidade Local de Saúde de Coimbra. Coimbra. Portugal.
  • Isabel Magalhães PULMONALE - Associação Portuguesa de Luta Contra o Cancro do Pulmão. Porto. Portugal.
  • Manuela França Serviço de Radiologia. Unidade Local de Saúde de Santo António. Porto. Portugal.; Instituto de Ciências Biomédicas de Abel Salazar. Universidade do Porto. Porto. Portugal.
  • Paula Fidalgo Serviço de Oncologia Médica. Unidade Local de Saúde de Santo António. Porto. Portugal.
  • Paulo Santos Centro de Investigação em Tecnologias e Serviços de Saúde (CINTESIS)/RISE. Faculdade de Medicina. Universidade do Porto. Portugal.
  • Venceslau Hespanhol Serviço de Pneumologia. Unidade Local de Saúde São João. Porto. Portugal.
  • António Araújo Serviço de Oncologia Médica. Unidade Local de Saúde de Santo António. Porto. Portugal.; Unit for Multidisciplinary Research in Biomedicine (UMIB). Instituto de Ciências Biomédicas Abel Salazar. Universidade do Porto. Porto. Portugal.

DOI:

https://doi.org/10.20344/amp.136

Keywords:

Lung Neoplasms/diagnosis, Lung Neoplasms/diagnostic imaging, Lung Neoplasms/epidemiology, Portugal

Abstract

N/a.

Downloads

Download data is not yet available.

References

Organization for Economic Cooperation and Development/European Union. Health at a Glance: Europe 2022: State of Health in the EU Cycle. Paris: OECD; 2022.

International Agency for research on Cancer. The Global Cancer Observatory WHO. Portugal, Globocan. 2020. [consultado 2023 set 01]. Disponível em: https://gco.iarc.who.int/media/globocan/factsheets/populations/620-portugal-fact-sheet.pdf.

Guerreiro T, Forjaz G, Antunes L, Bastos J, Mayerf A, Aguiar P, et al. Lung cancer survival and sex-specific patterns in Portugal: a population-based analysis. Pulmonology. 2023;29:s70-9. DOI: https://doi.org/10.1016/j.pulmoe.2021.09.001

Blandin Knight S, Crosbie PA, Balata H, Chudziak J, Hussell T, Dive C. Progress and prospects of early detection in lung cancer. Open Biol. 2017;7:170070. DOI: https://doi.org/10.1098/rsob.170070

National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409. DOI: https://doi.org/10.1056/NEJMoa1102873

de Koning HJ, van der Aalst CM, de Jong PA, Scholten ET, Nackaerts K, Heuvelmans MA, et al. Reduced lung-cancer mortality with volume ct screening in a randomized trial. N Eng J Med. 2020;382:503-13. DOI: https://doi.org/10.1056/NEJMoa1911793

Jonas DE, Reuland DS, Reddy SM, Nagle M, Clark SD, Weber RP, et al. Screening for lung cancer with low-dose computed tomography. JAMA. 2021;325:971. DOI: https://doi.org/10.1001/jama.2021.0377

Gómez-Carballo N, Fernández-Soberón S, Rejas-Gutiérrez J. Cost-effectiveness analysis of a lung cancer screening programme in Spain. Eur J Câncer Prev. 2022;31:235-44. DOI: https://doi.org/10.1097/CEJ.0000000000000700

European Commission. European Health Union: a new EU approach on cancer detection – screening more and screening better. [consultado 2023 jul 25]. Disponível em: https://ec.europa.eu/commission/presscorner/detail/en/ip_22_5562.

Poon C, Haderi A, Roediger A, Yuan M. Should we screen for lung cancer? A 10-country analysis identifying key decision-making factors. Health Policy. 2022;126:879-88. DOI: https://doi.org/10.1016/j.healthpol.2022.06.003

Lung Cancer Policy Network. Interactive map of lung cancer screening. 2023. [consultado 2023 jul 25]. Disponível em: https://www.lungcancerpolicynetwork.com/interactive-map-of-lung-cancer-screening/. DOI: https://doi.org/10.1007/978-3-031-33596-9_1

O’Dowd EL, Lee RW, Akram AR, Bartlett EC, Bradley SB, Brain K, et al. Defining the road map to a UK national lung cancer screening programme. Lancet Oncol. 2023;24:e207-18. DOI: https://doi.org/10.1016/S1470-2045(23)00104-3

Field JK, Duffy SW, Baldwin DR, Whynes DK, Devaraj A, Brain KE, et al. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening. Thorax. 2016;71:161-70. DOI: https://doi.org/10.1136/thoraxjnl-2015-207140

Crosbie PA, Balata H, Evison M, Atack M, Bayliss-Brideaux V, Colligan D, et al. Implementing lung cancer screening: baseline results from a Community based ‘Lung Health Check’ pilot in deprived areas of Manchester. Thorax. 2019;74:405-09. DOI: https://doi.org/10.1136/thoraxjnl-2017-211377

European Lung Foundation. About SOLACE. 2023. [consultado 2023 jul 25]. Disponível em: https://europeanlung.org/solace/about/.

van Meerbeeck JP, Franck C. Lung cancer screening in Europe: where are we in 2021? Transl Lung Cancer Res. 2021;10:2407-17. DOI: https://doi.org/10.21037/tlcr-20-890

Downloads

Published

2024-08-05

How to Cite

1.
Estevinho F, Parente B, Barata F, Magalhães I, França M, Fidalgo P, Santos P, Hespanhol V, Araújo A. Lung Cancer Screening in Portugal: A PULMONALE Pilot Project. Acta Med Port [Internet]. 2024 Aug. 5 [cited 2024 Nov. 24];37(10):677-81. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/136

Issue

Vol. 37 No. 10 (2024): October

Section

Perspective

License

Copyright (c) 2024 Acta Médica Portuguesa

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.

Crossref
Scopus
Google Scholar
Europe PMC